Together with IL-17, IL-22 seems to compromise the blood brain barrier integrity, enabling lymphocyte ingress into the CNS, which raises the possibility that this cytokine may contribute to MS severity [22]. This evidence concerns the gene IL22 and myeloid sarcoma.